IP Library Granted Patent US 10,077,250
Granted Patent B2
US 10,077,250 · App. 15/126,359 · Granted Sep 18, 2018

Antifungal compound process

Inventors: William J. Hoekstra (Durham, NC); Christopher M. Yates (Raleigh, NC); Mark Behnke (Poolesville, MD); Asaf Alimardanov (North Bethesda, MD); Scott A. David (Huntsburg, OH); Douglas Franklin Fry (Euclid, OH)
Assignees: Mycovia Pharmaceuticals, Inc.; Tlie United States of America, as represented by the Secretary, Department of Health and Human Services
C07D401/06C07D213/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,077,250
App. No.
15/126,359
Granted
Sep 18, 2018
Kind
B2
Abstract

The present invention relates to a process for preparing compound 1 that is useful as an antifungal agent. In particular, the invention seeks to provide new methodology for preparing compound 1 and substituted derivatives thereof.

Claims (12)

1. A process to prepare a compound of formula IX or IXa,

or a mixture thereof, the process comprising:

(i) combining compound 1 or 1a,

 or a mixture thereof, a sulfonic acid

 and a crystallization solvent or crystallization solvent mixture;

(ii) diluting the mixture from step (i) with a crystallization co-solvent or crystallization co-solvent mixture; and

(iii) isolating a compound of formula IX or IXa,

 or a mixture thereof;

wherein each Z is independently aryl, substituted aryl, alkyl, or substituted alkyl.

2. The process of claim 1 , wherein Z is phenyl, p-tolyl, methyl, or ethyl.

3. The process of claim 1 , wherein the crystallization solvent or crystallization solvent mixture is ethyl acetate, isopropyl acetate, ethanol, methanol, or acetonitrile, or combinations thereof.

4. The process of claim 1 , wherein the crystallization co-solvent or crystallization co-solvent mixture is pentane, methyl tert-butylether, hexane, heptane, or toluene, or combinations thereof.

Assignments (6)
CHANGE OF NAME Recorded Mar 28, 2018
From: VIAMET PHARMACEUTICALS (NC), INC.
To: MYCOVIA PHARMACEUTICALS, INC.
Reel/Frame 045759/0728 →
CHANGE OF NAME Recorded Jan 2, 2018
From: VIAMET PHARMACEUTICALS, INC.
To: VIAMET PHARMACEUTICALS (NC), INC.
Reel/Frame 044978/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2017
From: HOEKSTRA, WILLIAM J.; YATES, CHRISTOPHER M.
To: VIAMET PHARMACEUTICALS, INC.
Reel/Frame 040869/0444 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2017
From: RICERA BIOSCIENCES, LLC
To: UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 040858/0943 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2017
From: ALIMARDANOV, ASAF R.; BEHNKE, MARK L.
To: UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 041257/0632 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2017
From: FRY, DOUGLAS F.; DAVID, SCOTT A.
To: RICERA BIOSCIENCES, LLC
Reel/Frame 041257/0669 →
Continuity (2)
Provisional Application 61955532 · Mar 19, 2014
Related Publication 20170144990A1 · May 25, 2017